ABNCoV2 vaccine

ABNCoV2 · Bavarian Nordic

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABNCoV2 vaccine, covering 2024-09-27 to 2024-09-27. Get the full timeline:

Most recent: Clinical Trial Update: ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects [Phase 2]